You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Papillary Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Papillary Thyroid Tumors by Mass-ARRAY

Recruiting
  • Papillary Thyroid Cancer
  • Genotyping
  • Milan, MI, Italy
    Istituto Auxologico Italiano
Mar 10, 2023

PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS Trial (blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor

Not yet recruiting
  • PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
  • blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.
  • (no location specified)
Aug 17, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

Studies on Tumors of the Thyroid

Recruiting
  • Hurthle Cell Thyroid Cancer
  • +4 more
  • 68-Gallium Dotatate
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

Recruiting
  • Solid Tumor
  • +6 more
  • CM-24 and Nivolumab - Dose Escalation
  • +4 more
  • Scottsdale, Arizona
  • +10 more
Jan 17, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:

Terminated
  • Transitional Cell Carcinoma
  • +3 more
  • CG0070 Adenovirus Vector
  • Control Arm: Quadruple Choice
  • Phoenix, Arizona
  • +6 more
Apr 12, 2021

Treating Patients With Stage IV Breast Cancer

Active, not recruiting
  • Central Nervous System Metastases
  • +15 more
  • hyperfractionated radiation therapy
  • +2 more
  • North Chicago, Illinois
    University of Chicago
Dec 6, 2021

Bladder Cancer, Bladder Tumor, Bladder Tumors Trial in Hanover, New York, Philadelphia (Synergo® RITE + MMC)

Terminated
  • Bladder Cancer
  • +10 more
  • Synergo® RITE + MMC
  • Hanover, Maryland
  • +3 more
Apr 14, 2020

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory

Active, not recruiting
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • +5 more
  • Crizotinib (PF-02341066)
  • Brussels, Belgium
  • +24 more
May 9, 2022

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])

Recruiting
  • Papillary Renal Cell Carcinoma Type 2
  • Axitinib Oral Tablet [Inlyta]
  • Pembrolizumab Injection [Keytruda]
  • Angers, France
  • +11 more
Aug 26, 2022

Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

Recruiting
  • Papillary Thyroid Cancer
    • Milan, Italy
      Istituto Auxologico Italiano
    Mar 2, 2023

    Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

    Available
    • Clear Cell Kidney Cancer
    • +2 more
    • Axitinib 5 MG
    • (no location specified)
    Jul 3, 2023

    Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

    Recruiting
    • Metastatic Papillary Renal Cell Carcinoma
    • Stage IV Renal Cell Cancer AJCC v8
    • Atezolizumab
    • +4 more
    • Sacramento, California
    • +38 more
    Jan 17, 2023

    Concordance of Molecular Classification Based on Fine Needle

    Not yet recruiting
    • Papillary Thyroid Cancer
      • Calgary, Alberta, Canada
        Foothills Medical Centre
      Nov 17, 2023

      Kidney Cancer Trial run by the NCI (INC280)

      Completed
      • Kidney Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 18, 2021

      Fascial Versus Standard Neck Dissection in N1b Papillary Thyroid

      Completed
      • Patients With Papillary Thyroid Cancer and N1b Status
      • Fascial Neck Dissection
      • Standard Neck Dissection
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Mar 27, 2023

      Positron-Emission Tomography, Lymph Node Metastases, Thyroid Cancer Trial in Guangzhou (<Sup>18<Sup>F-FDG PET/CT dynamic scan,

      Recruiting
      • Positron-Emission Tomography
      • +2 more
      • <Sup>18<Sup>F-FDG PET/CT dynamic scan
      • B-ultrasonography
      • Guangzhou, Guangdong, China
        Fifth Affiliated Hospital, Sun Yat-Sen University
      Jul 27, 2022

      Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

      Available
      • Non Small Cell Lung Cancer
      • +6 more
      • Goodyear, Arizona
      • +67 more
      Aug 17, 2022

      Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

      Recruiting
      • Breast Cancer
      • +15 more
      • Goodyear, Arizona
      • +146 more
      Aug 24, 2022

      Cross-sectional Case and Control Study on Quality of Life,

      Recruiting
      • Papillary Thyroid Carcinoma
      • Thyroid Cancer
      • Thyroid lobectomy via trans-axillary approach
      • Thyroid lobectomy via open approach
      • Beijing, Beijing, China
        Department of General Surgery, Peking Union Medical College Hosp
      Jul 5, 2023

      Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

      Not yet recruiting
      • Advanced Clear Cell Renal Carcinoma (Ccrcc)
      • Papillary Renal Cell Carcinoma (Prcc)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Biomarkers of Renal Cancer

      Recruiting
      • Renal Cell Carcinoma
      • +3 more
        • Firenze, Italy
        • +3 more
        Mar 14, 2023